Normal view MARC view ISBD view

Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS [electronic resource]

By:

Caspar, Achim T

Contributor(s):

Producer: 20170523Description: 158-169 p. digitalISSN:

1873-264X

Subject(s):

Online resources:

Available from publisher's website

In: Journal of pharmaceutical and biomedical analysis vol. 134

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Well-being of a baby breast fed by her mother on carbimazol treatment.
by Verd, S
2 [Attention deficit hyperactivity disorder: the state of the matter and further research approaches].
by Cardo, E
3 [ADHD Rating Scale-IV in a sample of Spanish schoolchildren: normative data and internal consistency for teachers and parents].
by Servera, M
4 [Prenatal cerebrovascular accidents: their incidence, pathogenesis and risk factors].
by Cardó, E
5 [The prevalence of attention deficit hyperactivity disorder].
by Cardo, E
6 [The role of resistance to C active protein (R-APC) in a pediatric stroke].
by Cardo, E
7 [Estimation of the prevalence of attention deficit hyperactivity disorder among the standard population on the island of Majorca].
by Cardo, E
8 [The predictive value of DSM-IV criteria in the diagnosis of attention deficit hyperactivity disorder and its cultural differences].
by Cardo, E
9 Macrocephaly and dilated Virchow-Robin spaces in childhood.
by Artigas, J
10 [Methylphenidate in the treatment of attention-deficit/hyperactivity disorder: are we achieving an adequate clinical practice?].
by Gonzalez de Dios, J
11 Phosphomannomutase deficiency and normal pubertal development.
by Artigas, J
12 [Soft neurological signs: are they of any value in the assessment and diagnosis of attention deficit hyperactivity disorder?].
by Cardo, E
13 [Risk factors in cerebrovascular disease in childhood].
by Cardo, E
14 Evaluation of hyperhomocysteinaemia in children with stroke.
by Cardo, E
15 Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status.
by Cardo, E
16 [Oppositional defiant disorder: aspects related to sex differences and informant].
by Cardo, E
17 Fatal haemorrhagic infarct in an infant with homocystinuria.
by Cardo, E
18 [What combination of symptoms according to parents and teachers would be more reliable for the diagnosis of ADHD?].
by Cardo, E
19 Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene.
by Vilaseca, M A
20 [Attention deficit disorder and hyperactivity: a pattern of evolution?].
by Cardo, E